STEGLUJAN

ERTUGLIFLOZIN AND SITAGLIPTIN · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for STEGLUJAN, covering 2017-12-19 to 2025-11-21. Get the full timeline:

Most recent: EMA Authorised: Steglujan (ertugliflozin l-pyroglutamic acid;sitagliptin phosphate monohydrate) — Merck Sharp & Dohme B.V.